# Tofacitinib

NDC: 33342-541
Generic name: Tofacitinib
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260603

FDA application: ANDA219530

## Active ingredients

- TOFACITINIB CITRATE: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-541"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-541
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b654f0d-7705-4880-9e9d-ad3a51e56b56